Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

PSA Worthless for Prostate Cancer Screening?

'PSA Era Over,' Test's Pioneer Now Says
WebMD Health News

Sept. 10, 2004 -- PSA screening for prostate cancer is dead, one of the test's earliest advocates now says.

PSA stands for prostate-specific antigen. It's a protein thrown off by a growing prostate gland. Growing prostate cancers give off a lot of PSA. So blood tests for PSA are widely used as an early warning system for prostate cancer.

Men with a PSA level of 4.0 or more are almost always sent to a urologist for a prostate biopsy. And men with a positive biopsy usually opt for surgery or radiation therapy.

Experts disagree on how often, or even if, men should have their PSA regularly checked. Some experts recommend annual PSAs starting at age 50 -- or age 40 for men at high risk of prostate cancer, such as black men or men with a family history of it.

But there's no proof that PSA screening saves lives. Thomas A. Stamey, MD, founding chairman of the Stanford University urology department, led many of the studies that led to the wide acceptance of PSA screening. Now, Stamey says, the PSA era is over.

"You can biopsy according to whether a man has blue eyes or green eyes and get pretty much the same results as biopsying according to PSA," Stamey tells WebMD. "We can't understand this disease except by first knowing we men all get it, and, second, by knowing that we are very unlikely to die from it."

Stamey says that to put PSA screening into context, two things must be understood:

  • Nearly all men eventually get prostate cancer. It's found in some 8% of men in their 20s and in 80% of men in their late 70s, Stamey says.
  • Relatively few men die of prostate cancer. In the U.S., Stamey says, there are 226 prostate-cancer deaths for every 100,000 men. So a man has only a 0.2% chance of dying from the disease.

20 Years and 1,317 Prostates

Stamey's latest findings -- reported in the October issue of the Journal of Urology -- come from a study of 1,317 prostate glands removed by the same surgeon between 1983 and 2003. All of the patients had PSA tests. All had biopsies that showed signs of cancer.

1 | 2 | 3 | 4

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D